Alpha Tau Medical (DRTS) Debt to Equity (2023 - 2025)

Alpha Tau Medical has disclosed Debt to Equity across 3 years of filings, most recently posting $0.08 for Q4 2025.

• Debt to Equity for Q4 2025 came in at $0.08, down 7.16% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.08 (down 7.16% YoY), and the FY2025 annual result was $0.08, down 7.16% from the prior year.
• Debt to Equity came in at $0.08 for Q4 2025 at Alpha Tau Medical, down from $0.09 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.09 in Q4 2024 to a low of $0.07 in Q4 2023.
• The 3-year median for Debt to Equity is $0.08 (2025), against an average of $0.08.
• Across the five-year window, Debt to Equity soared 33.62% in 2024 and slipped 7.16% in 2025, its largest moves.
• Alpha Tau Medical's Debt to Equity stood at $0.07 in 2023, then jumped by 33.62% to $0.09 in 2024, then dropped by 7.16% to $0.08 in 2025.
• The last three Debt to Equity figures came in at $0.08 (Q4 2025), $0.09 (Q4 2024), and $0.07 (Q4 2023), per Business Quant data.